Neucardin^®——(AMI)

      Acute Myocardial Infarction（AMI） has high morbidity and mortality around the world. AMI, due to the sharp reduction or interruption of coronary blood supply, can lead to irreversible myocardial cell damage or death. Due to the lack of available treatments, the AMI patient mortality rate remains high.

      According to preclinical findings, Neucardin® can effectively improve the cardiac function of acute myocardial infarction model rats, reduce the incidence of heart failure caused by myocardial infarction, and improve the prognosis of acute myocardial infarction by protecting and repairing myocardial injury.